Goodwin Procter advised Sionna Therapeutics, Inc., and Ropes & Gray advised the underwriters in the offering.Sionna Therapeutics (Nasdaq: SION) (Sionna) announced its initial public offering of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
